BDBM50240437 (-)-17-(cyclobutylmethyl)morphinan-3,14-diol::(-)-N-cyclobutylmethyl-3,14-dihydroxymorphinan::(-)-butorphanol::17-(cyclobutylmethyl)morphinan-3,14-diol::BUTORPHANOL::CHEMBL33986::US10231963, Table B.3::US10736890, Compound TABLE B.3::US11534436, Compound Table B.3::US9656961, Example 00120

SMILES Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1

InChI Key InChIKey=IFKLAQQSCNILHL-QHAWAJNXSA-N

Data  13 KI  10 IC50  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50240437   

TargetMu-type opioid receptor(Homo sapiens (Human))
Alkermes Pharma Ireland

US Patent
LigandPNGBDBM50240437((-)-17-(cyclobutylmethyl)morphinan-3,14-diol | (-)...)
Affinity DataKi:  0.190nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

TargetMu-type opioid receptor(Homo sapiens (Human))
Alkermes Pharma Ireland

US Patent
LigandPNGBDBM50240437((-)-17-(cyclobutylmethyl)morphinan-3,14-diol | (-)...)
Affinity DataIC50:  28nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

TargetMu-type opioid receptor(Homo sapiens (Human))
Alkermes Pharma Ireland

US Patent
LigandPNGBDBM50240437((-)-17-(cyclobutylmethyl)morphinan-3,14-diol | (-)...)
Affinity DataEC50:  3.30nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank